Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q3V6T2 (
ape
)
2,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The tracheo-bronchial mucosa of 27 surgical patients with
esophageal cancer
was examined by bronchofiberscope postoperatively, and the changes of the mucosa were divided into four grades, i.e., GI: no change or slight redness only (7 cases), GII: Severe redness or erosion (7 cases), GIII: Ulcer formation (11 cases) and
GIV
: Necrosis of the mucosa (2 cases). All the GI-III changes were reversible. However,
GIV
change was irreversible. The biopsy specimens were taken from the mucosa of the tracheal bifurcation on the 7th postoperative day, showing squamous metaplasia in 9 of 13 patients. Bilateral modified neck and upper mediastinal lymph node dissections were performed in 18 of 27 patients. The change of the mucosa was judged as GIII or IV in 12 of 18 patients (67%), whereas the change was less significant in the remaining 6 patients. Namely, the degree of mucosal change did not necessarily correspond with the extent of lymph node dissection. The changes of the mucosa were considered to be brought about not only by tracheo-bronchial ischemia but also by injurious effects on the pulmonary parenchyma following aggressive lymph node dissection. The assessment of the degree of the mucosal change might be a useful indicator for postoperative management of
esophageal cancer
patients.
...
PMID:[A study on the changes in the tracheo-bronchial mucosa after esophagectomy for esophageal cancer; with special reference to the influence of neck and upper mediastinal lymph node dissections]. 260 15
The actin-binding protein
Girdin
is a hub protein that interacts with multiple proteins to regulate motility and Akt and trimeric G protein signaling in cancer cells.
Girdin
expression correlates with poor outcomes in multiple human cancers. However, those findings are not universal, as they depend on study conditions. Those data suggest that multiple aspects of
Girdin
function and its role in tumor cell responses to anticancer therapeutics must be reconsidered. In the present study, we found that
Girdin
is involved in DNA damage-induced cancer cell apoptosis. An
esophageal cancer
cell line that exhibited high
Girdin
expression showed a marked sensitivity to UV-mediated DNA damage compared to a line with low
Girdin
expression. When transcriptional activation of endogenous
Girdin
was mediated by an engineered CRISPR/Cas9 activation system, sensitivity to DNA damage increased in both stationary and migrating HeLa cancer cells. High
Girdin
expression was associated with dysregulated cell cycle progression and prolonged G
1
and M phases. These features were accompanied by p53 activation, which conceivably increases cancer cell vulnerability to UV exposure. These data highlight the importance of understanding complex
Girdin
functions that influence cancer cell sensitivity to therapeutics.
...
PMID:Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells. 3287 99